Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is N/A as of the fiscal period ended Tuesday, March 31, 2026.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q1 FY2026 (2026-03-31): -243.74%.
RETURN ON INVESTED CAPITAL (ROIC)
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-122.18%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-73.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-74.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Gossamer Bio, Inc.
Market Cap
$65.87M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-122.18%
3Y Avg
-73.82%
5Y Avg
-74.09%
Market Cap
$65.86M
Return on Invested Capital (ROIC)
-83.74%
TTM Avg
-153.15%
3Y Avg
-164.21%
5Y Avg
-165.99%
Market Cap
$65.85M
Return on Invested Capital (ROIC)
-37.01%
TTM Avg
-30.52%
3Y Avg
-23.08%
5Y Avg
-17.79%
Market Cap
$67.52M
Return on Invested Capital (ROIC)
-40.22%
TTM Avg
-72.23%
3Y Avg
-74.75%
5Y Avg
-58.95%
Market Cap
$64.18M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-165.22%
3Y Avg
-160.52%
5Y Avg
-107.11%
Market Cap
$63.78M
Return on Invested Capital (ROIC)
-56.22%
TTM Avg
-67.31%
3Y Avg
-52.91%
5Y Avg
-45.67%
Market Cap
$68.10M
Return on Invested Capital (ROIC)
-10.85%
TTM Avg
-101.00%
3Y Avg
-120.85%
5Y Avg
-96.47%
Market Cap
$63.02M
Return on Invested Capital (ROIC)
-4.72%
TTM Avg
-4.96%
3Y Avg
-2.45%
5Y Avg
-3.32%
Market Cap
$68.90M
Return on Invested Capital (ROIC)
13.12%
TTM Avg
-58.05%
3Y Avg
-35.80%
5Y Avg
-42.97%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | $65.87M | N/A | -122.18% | -73.82% | -74.09% |
| Cingulate Inc. (CING)vs › | $65.86M | -83.74% | -153.15% | -164.21% | -165.99% |
| XBiotech Inc. (XBIT)vs › | $65.85M | -37.01% | -30.52% | -23.08% | -17.79% |
| iBio, Inc. (IBIO)vs › | $67.52M | -40.22% | -72.23% | -74.75% | -58.95% |
| Alps Group Inc (ALPS)vs › | $64.18M | N/A | -165.22% | -160.52% | -107.11% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | -56.22% | -67.31% | -52.91% | -45.67% |
| Fortress Biotech, Inc. (FBIO)vs › | $68.10M | -10.85% | -101.00% | -120.85% | -96.47% |
| InterCure Ltd. (INCR)vs › | $63.02M | -4.72% | -4.96% | -2.45% | -3.32% |
| Spero Therapeutics, Inc. (SPRO)vs › | $68.90M | 13.12% | -58.05% | -35.80% | -42.97% |
| Heron Therapeutics, Inc. (HRTX)vs › | $62.78M | -6.79% | -4.87% | -47.70% | -62.00% |
ROIC
N/A
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-03-31 | -243.74% |
| 2025-12-31 | -156.90% |
| 2025-09-30 | -108.94% |
| 2025-06-30 | -77.74% |
| 2025-03-31 | -23.57% |
| 2024-12-31 | -22.17% |
| 2024-09-30 | -24.29% |
| 2024-06-30 | -24.18% |
| 2024-03-31 | -76.26% |
| 2023-12-31 | -67.58% |
| 2023-09-30 | -59.61% |
| 2023-06-30 | -133.55% |
| 2023-03-31 | -111.13% |
| 2022-12-31 | -93.08% |
| 2022-09-30 | -76.42% |
| 2022-06-30 | -101.17% |
| 2022-03-31 | -83.53% |
| 2021-12-31 | -71.14% |
| 2021-09-30 | -63.95% |
| 2021-06-30 | -55.26% |
| 2021-03-31 | -51.26% |
| 2020-12-31 | -46.72% |
| 2020-09-30 | -41.64% |
| 2020-06-30 | -37.84% |
| 2020-03-31 | -60.36% |
| 2019-12-31 | -47.77% |
| 2019-09-30 | -38.97% |
| 2019-06-30 | -35.48% |
| 2019-03-31 | -31.97% |
| 2018-12-31 | -68.03% |
| 2018-09-30 | -46.72% |
| 2018-06-30 | -135.63% |
